The Joel and Roberta Porter Visiting Professor Lecture Cataract and Primary Eye Care - John Berdahl, MD [NON-CME]

Click here to register for the livestream!

In this series, we welcome influential ophthalmologists from around the country and the world to speak at Wills Eye Hospital for the benefit of residents and practicing ophthalmologists. Presentations and lectures include clinical and non-clinical content, and reflections on each guest's professional journey. 

Dr. Berdahl is most motivated by the trust his patients place in him during their moments of vulnerability. That patient trust has, first and foremost, driven him to become an accomplished surgeon. However, as he meets patient needs and learns more about the problems they face, he’s had several opportunities to stretch his skills as an inventor and problem-solver. He co-invented the MKO melt, an innovation used in our Sioux Falls clinic that provides sedation during cataract surgery without the use of an IV or opioids, and developed Interfeen, a rare disease drug that helps with ocular conditions. He created astigmatismfix.com, a resource that has helped tens of thousands of surgeons eliminate residual astigmatism after cataract surgery, and he co-founded ExpertOpinion.MD, a site where patients can request medical opinions from authentic world experts. He also is the founder of Balance Ophthalmics, the first non-surgical, non-pharmacologic way to lower eye pressure for glaucoma treatment, which was FDA approved in 2024.

Dr. Berdahl is equipped to employ the most innovative and tested techniques available to effectively treat most diseases of the anterior segment (front part of the eye). He is exceptionally skilled at diagnosing the best treatment for varying stages of glaucoma, corneal diseases, and cataracts. He is also a meticulous refractive surgeon. To advance the technologies available to our patients, Dr. Berdahl collaborates with numerous ophthalmology companies as a consultant. However, to minimize potential bias, all consulting fees are donated to charity.

This series is not certified for CME credit. 

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.